3rd Quarter - Report
BAKER & HOSTETLER LLP for ADVAXIS, INC.
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 related to the Breakthrough Therapy Designation for pharmaceuticals. Policy issues related to Public Law 114-221, the 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
| TYLER THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.